Elsevier,
JACEP Open, Volume 5, June 2024
This article provides an overview of the Age‐Friendly Emergency Department (AFED) model, a crucial component of a holistic age‐friendly health system with the potential to improve patient‐centered outcomes, reduce adverse events and hospitalizations, and enhance functional recovery. Age‐friendly healthcare is a comprehensive approach using the 4Ms framework—what matters, medications, mentation, and mobility—to ensure that healthcare settings are responsive to the needs of older patients.
Elsevier,
hLife, Volume 2, June 2024
In the Han Chinese populations on the Mongolian Plateau, the MTHFR G677A mutation is associated with increased homocysteine levels, which are linked to a higher risk of Alzheimer's disease. This genetic variant highlights the potential impact of folate metabolism on neurodegenerative conditions in this specific population.
Elsevier,
Pharmacology and Therapeutics, Volume 258, June 2024
The review summarizes and discusses the potential role of psilocybin, a psychedelic compound, in altering mechanisms associated with major depression and neurodegenerative diseases. It examines the relationship between adult hippocampal neurogenesis, microglial activity, and their implications for the development of dementia, particularly in the context of major depression as a risk factor.
Elsevier, Telematics and Informatics Reports, Volume 14, June 2024
This paper addresses the underexplored environmental impacts of ICT by systematically reviewing 70 studies, identifying common assessment methods and mechanisms, and categorizing solutions into eight main classes within a comprehensive framework. It also evaluates how these solutions align with the UN Sustainable Development Goals, highlighting research gaps and policy implications to better mitigate ICT’s adverse environmental effects.
Journal of Pharmaceutical Analysis, 2024, 101022, ISSN 2095-1779
This study developed four deep learning models to identify potential Alzheimer's disease treatments from traditional Chinese medicine, specifically the Kaixinsan formula. The models successfully predicted compounds that showed significant anti-Alzheimer's activities in various experimental validations.
